Verily employees combine expertise in engineering, machine learning, biology, and medicine to change the way healthcare happens. Our work spans three primary areas: research, innovation, and care; the focus of the internship is on the first two. Verily Israel is particularly interested in medical problems that can be solved by the application of algorithms in machine learning, computer vision, and signal processing, including problems that involve the use of novel sensors.
Verily Israel has focused on problems in endoscopy and minimally invasive surgery, and is currently expanding this scope to include other biomedical problems of interest. Other large scale Verily programs include Project Baseline - our research initiative to increase participation and evidence generation in clinical research; Onduo - our chronic disease management platform, which began with type 2 diabetes; and Debug - our effort to reduce the threat of mosquito-borne diseases by combining machine learning with sterile insect technique. We’re also actively working to combat the spread of COVID-19 through new programs like Healthy at Work.
Verily Life Sciences, also known as Verily, is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc.
Tel Aviv, Israel